Atlas Venture is a leading biotech venture capital firm.  Atlas companies are custom built to realize their scientific and business potential.

DISCOVER: Identifying true innovation from high-impact science.

DERISK: Proving and maturing the science and technology to guide clinical translation

SHAPE: Crafting the right business model for each opportunity.

STRENGTHEN: Rolling up our sleeves to position our companies for successful drug development and exits in all market environments.

Employee Rating

4.0
TypeInvestor
HQCambridge, US
Founded1984
Websiteatlasventure.com
Atlas Venture was founded in 1984 and is headquartered in Cambridge, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Atlas Venture

Peter Barrett

Peter Barrett

Partner
David Grayzel

David Grayzel

Partner
Jason Rhodes

Jason Rhodes

Partner
Jean-Francois Formela

Jean-Francois Formela

Partner
Bruce Booth

Bruce Booth

Partner
Kevin Bitterman

Kevin Bitterman

Partner
Show more

Atlas Venture Office Locations

Atlas Venture has an office in Cambridge
Cambridge, US (HQ)
400 Technology Square
Show all (1)
Report incorrect company information

Atlas Venture News and Updates

Akrevia Therapeutics Launches with $30M Series A Financing Led by F-Prime Capital Partners and Atlas Venture

CAMBRIDGE, Mass., Sept. 27, 2018 /PRNewswire/ -- Akrevia Therapeutics, a privately-held biopharmaceutical company focused on developing highly-potent, tumor-targeted immuno-oncology therapeutics, today announced the closing of a $30 million Series A financing led by F-Prime Capital...

Atlas Venture wraps up 11th fund at $350 mln

Cambridge, Massachusetts-based Atlas Venture, an early-stage venture firm, has closed its oversubscribed 11th fund at $350 million. Altas Ventures invests in biotech startups.
Report incorrect company information

Atlas Venture Blogs

Partnered with Novartis, tiny Cadent jumps out of stealth with $40M round for its CNS pipeline

A small Cambridge, Massachusetts-based company is hoping its bet on CNS drugs using a well established pharmaceutical approach — allosteric modulators — will cement its place as a biotech powerhouse in the years to come. Cadent Therapeutics — currently a 9-person team — has already found a partner i…

Fleece vs Future: How Small Companies Can Help Build Biotech Talent

A lot has been written about the biotech talent war in the Boston area including the availability of talent as the major limitation to venture creation and the increasingly lavish perks designed to attract and retain experienced staff. As the leader of an organization attempting to grow within this …

Kymera raises $65M from global syndicate as it aims for the clinic with protein degradation tech

You can add Kymera Therapeutics to the list of biotechs attracting attention from an international set of investors. Read more. The post Kymera raises $65M from global syndicate as it aims for the clinic with protein degradation tech appeared first on Atlas Venture.

2018’s Biotech IPO Bonanza: View From the After Market

2018 has so far been another gangbuster year for biotech IPOs: the first three quarters of the year have delivered nearly 50 new biotech offerings, reinforcing the strong new issuance performance of the past 6 years. Read more. The post 2018’s Biotech IPO Bonanza: View From the After Market appeared…

Science2Startup 2019: Bringing Venture & Academia Together

After last year’s inaugural success, we’re excited for 2019’s Science2Startup conference in April 2019, an invitation-only university-focused biotech entrepreneurship event aimed at building connectivity across the academic, tech transfer, and venture communities. Read more. The post Science2Startup…

Targeting Aging Comes Of Age

We finally are beginning to understand the biological basis of aging and age-related diseases, making the discovery of new therapies actionable for the first time. This blog is written by Tom Hughes, CEO of Navitor Pharma, as part of the From The Trenches feature of LifeSciVC. Read more. The post Ta…
Show more

Atlas Venture Company Life and Culture

Report incorrect company information

Atlas Venture Frequently Asked Questions

  • When was Atlas Venture founded?

    Atlas Venture was founded in 1984.

  • Who are Atlas Venture key executives?

    Atlas Venture's key executives are Peter Barrett, David Grayzel and Jason Rhodes.

  • Where is Atlas Venture headquarters?

    Atlas Venture headquarters is located at 400 Technology Square, Cambridge.

  • Where are Atlas Venture offices?

    Atlas Venture has an office in Cambridge.

  • How many offices does Atlas Venture have?

    Atlas Venture has 1 office.